Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Lourdes Ibanez"'
Autor:
Judit Bassols, Francis de Zegher, Marta Diaz, Gemma Carreras‑Badosa, Cristina Garcia‑Beltran, Elsa Puerto‑Carranza, Cora Oliver‑Vila, Paula Casano, Celine Alicia Franco, Rita Malpique, Abel Lopez‑Bermejo, Lourdes Ibanez
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/12ee5c78f1784bf88aa6043aa9157641
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Anales de Pediatría (English Edition), Vol 101, Iss 2, Pp 124-131 (2024)
Newborns who do not reach a weight appropriate for their gestational age and sex can be classified in different ways. This article defines the concepts of small for gestational age (SGA) and intrauterine growth restriction, as well as the underlying
Externí odkaz:
https://doaj.org/article/dc7e0dec84c848a78283c613fc7f91ce
Autor:
Lourdes Ibanez, Zegher Francis de
Publikováno v:
Endocrine Abstracts.
Autor:
Lourdes Ibanez, Francis de Zegher, Rita Malpique, Firdevs Bas, Feyza Darendeliler, Flaminia Fanelli, Alessandra Gambineri, Judit Bassols, Abel Lopez-Bermejo, Barbara Obermayer-Pietsch, Veronika Tandl, Dorte Glintborg, Pernille Ravn, Barbara Dieris, Viola Singer, Thomas Reinehr, Ronnaug Odegard, Eszter Vanky
Publikováno v:
Journal of the Endocrine Society. 6:A668-A668
Introduction PCOS in adolescent girls and young women is nowadays thought to be, in essence, an epiphenomenon of ectopic fat accumulation. By definition, "adolescent PCOS" is characterized by androgen excess (as well clinical as biochemical) and olig
Autor:
Mitchell E Geffner, Lourdes Ibanez, Aristides Maniatis, Daria L Torre, Carol Huang, Feyza Darendelieler, Mehul Dattani, Mohamad Maghnie, Moshe Phillip, Jovanna Dahlgren, Reiko Horikawa, Roy Gomez, Scott P Kelly, Michael P Wajnrajch
Publikováno v:
Journal of the Endocrine Society. 6:A630-A630
Background Children with growth hormone deficiency (GHD) are treated with recombinant human growth hormone (rhGH), usually administered as a daily subcutaneous injection. Long-acting hGH (LAGH) treatments (approved and in development) have the potent
Autor:
Cristina Garcia-Beltran, Marion Peyrou, Artur Navarro-Gascon, Abel López-Bermejo, Francis de Zegher, Francesc Villarroya, Lourdes Ibáñez
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionPolycystic ovary syndrome (PCOS) is often associated with metabolic-associated fatty liver disease (MAFLD). MAFLD has been associated with altered hepatic function, systemic dysmetabolism, and abnormal circulating levels of signaling mole
Externí odkaz:
https://doaj.org/article/4c895d1ffc464689914490efdd1d86d1
This volume comprehensively focuses on polycystic ovary, metabolic syndrome and obesity and their impact on women's health, reproduction and quality of life from adolescence to old age.PCOS is analyzed form the early origins - highlighting the import
Autor:
Emma Barroso, Marta Díaz, Ana Cristina Reguera, Mona Peyman, Jesús Balsinde, Javier Jurado-Aguilar, Meijian Zhang, Adel Rostami, Xavier Palomer, Lourdes Ibáñez, Manuel Vázquez-Carrera
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background The placentas from newborns that are small for gestational age (SGA; birth weight
Externí odkaz:
https://doaj.org/article/0dde09ae81aa407db201bf013672fee5
Autor:
Cristina Garcia-Beltran, Rita Malpique, Marianne S. Andersen, Firdevs Bas, Judit Bassols, Feyza Darendeliler, Marta Díaz, Barbara Dieris, Flaminia Fanelli, Elke Fröhlich-Reiterer, Alessandra Gambineri, Dorte Glintborg, Abel López-Bermejo, Christopher Mann, Silvia Marin, Barbara Obermayer-Pietsch, Rønnaug Ødegård, Pernille Ravn, Thomas Reinehr, Matteo Renzulli, Cristina Salvador, Viola Singer, Eszter Vanky, Juan Vicente Torres, Melek Yildiz, Francis de Zegher, Lourdes Ibáñez
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-25 (2023)
Abstract Background Polycystic ovary syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affecting 5–10% of AYAs worldwide. There is no approved pharmacological therapy for PCOS. Standa
Externí odkaz:
https://doaj.org/article/cd01e82c8557468c8c62a5200d948371